Etcamah (Camizestrant) Is FDA Approved — and Some KOLs Still Agree With ODAC's No Vote
SERENA-6 KOL sentiment after the Etcamah (camizestrant) FDA approval: Tatiana Prowell, Angela DeMichele's ASCO plenary takeaways, Gyawali and other voices who s…
Gedatolisib (Revtorpyk) Is FDA Approved: What Breast Oncology KOLs Said on Day One
What breast oncology KOLs said within hours of the gedatolisib (Revtorpyk) FDA approval: doublet vs triplet, weekly-IV burden, and the 2.0-month control arm.
Dr. Vinay Prasad's Views on Key ASCO Breast Cancer Trials
Dr. Vinay Prasad is now Director of FDA's CBER Division, Review his thoughts on NATALEE, DESTINY-Breast04, and postMONARCH breast cancer clinical trials
DESTINY-Breast09 is Trending, What About PATINA?
Breast Cancer experts from the global KOL community have been buzzing about DESTINY-Breast09 and PATINA clinical trials. Track their social media insights.